Welcome to our dedicated page for Constelltn Bnds SEC filings (Ticker: STZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Constellation Brands, Inc. (NYSE: STZ) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Constellation Brands is an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy, and its filings offer detailed insight into how management reports on these businesses.
Investors can review Form 8-K filings where the company reports quarterly financial results, updates to its fiscal outlook, and other material events. These 8-Ks often include or reference earnings releases that discuss segment performance in beer and wine and spirits, non-GAAP measures described as comparable, adjusted, or organic, and reconciliations to GAAP metrics. They also cover Board actions such as quarterly cash dividend declarations on Class A Common Stock and Class 1 Convertible Common Stock.
Filings further document capital structure and financing activities, including automatic shelf registration statements on Form S-3, prospectus supplements for equity resales, and the terms of senior notes offerings and related indentures. Recent 8-Ks describe the pricing and issuance of 4.950% Senior Notes due 2035, the termination of a delayed draw term loan credit agreement, and associated legal opinions filed as exhibits.
Other SEC disclosures capture governance and management changes, such as amendments and restatements of the company’s by-laws, senior management transitions, and executive employment agreements. With real-time updates from EDGAR and AI-powered summaries, this page helps users quickly understand the key points from lengthy filings, including quarterly and annual reports and any insider- or capital-markets-related disclosures that shape the Constellation Brands investment profile.
CONSTELLATION BRANDS, INC. executive Jeffrey H. LaBarge, EVP, CLO, & Secretary, filed an initial Form 3 reporting his existing equity holdings in the company. The filing lists several non-qualified stock options, multiple tranches of restricted stock units (RSUs), and 4,390 shares of Class A Common Stock held directly as of March 1, 2026.
Footnotes explain that some options are already 100% exercisable, while others become exercisable in three or four equal annual installments beginning on specified grant dates. The RSUs each represent a contingent right to receive one share of Class A Common Stock and vest in three or four equal annual installments, with shares delivered on each vesting date after tax withholding.
Glaetzer Samuel J reported open-market sale transactions in a Form 4 filing for STZ. The filing lists transactions totaling 555 shares at a weighted average price of $153.78 per share. Following the reported transactions, holdings were 2,615 shares.
A holder of STZ common stock filed a Form 144 indicating an intention to sell 555 shares through Morgan Stanley Smith Barney LLC on or about February 17, 2026. The filing lists an aggregate market value of $85,345.13 for these shares. The issuer had 173,384,625 shares outstanding at the time referenced. The shares to be sold were originally acquired as restricted stock vesting under a registered plan on May 1, 2023, directly from the issuer, with payment noted as not applicable.
Constellation Brands announced a planned CEO transition. The Board appointed Nicholas Fink as President and CEO effective April 13, 2026, succeeding Bill Newlands. Fink, currently CEO of Fortune Brands Innovations and a Constellation director since 2021, will remain on the Board.
Fink’s employment agreement sets an initial annual base salary of $1.4 million, a Fiscal 2027 bonus target at 160% of base salary, and a Fiscal 2027 long‑term equity award with grant date fair value of $11 million. He will also receive a replacement equity award of 85,385 restricted stock units and 415,295 stock options, vesting over three years, plus up to $50,000 in legal fee reimbursement.
If his agreement expires or he has a qualifying termination, Fink is eligible for cash severance equal to twice base salary and twice his average bonus, 24 months of medical and dental payments, and 18 months of outplacement services. Newlands will serve as Strategic Advisor from April 13 to April 30, 2026, then as a consultant through December 31, 2026 for a total fee of $1.2 million.
Constellation Brands, Inc. reports much higher profitability for the nine months ended November 30, 2025, despite lower revenue. Net sales were $7,218.8 million versus $8,044.5 million a year earlier, but net income attributable to CBI jumped to $1,484.9 million from $293.9 million, with diluted earnings per Class A share rising to $8.43 from $1.61. Operating income improved sharply as the prior year included a $2,250.0 million goodwill impairment in the Wine and Spirits business.
The company reshaped its portfolio, selling mainstream wine and spirits assets in the 2025 Wine Divestitures for cash proceeds of $845.9 million and recording a $31.0 million loss on the sale, and divesting the SVEDKA brand earlier in 2025. Cash flow from operations was strong at $2,106.2 million, helping fund $656.1 million of capital spending, $824.1 million of share repurchases, and $538.8 million of dividends. Long-term debt stood at $10,285.1 million after issuing new May 2025 and October 2025 senior notes and redeeming or repaying several older notes. The ongoing 2025 Restructuring Initiative has generated $106.1 million of cumulative pre-tax costs to date, with total costs now estimated at $110 million to $130 million.
Constellation Brands, Inc. reported that it has released its financial condition and operating results for the third fiscal quarter ended November 30, 2025 through a news release furnished as Exhibit 99.1. The release includes management’s guidance and uses non-GAAP measures described as comparable, adjusted, and organic, with reconciliations to GAAP provided for transparency.
The company’s board also declared a quarterly cash dividend of $1.02 per share on Class A Common Stock and $0.92 per share on Class 1 Convertible Common Stock, payable on February 12, 2026 to shareholders of record as of the close of business on January 29, 2026. The financial information in the release is being furnished, not filed, under the securities laws, which limits certain legal liabilities.
Constellation Brands, Inc. is the subject of a Schedule 13G/A in which Warren E. Buffett, Berkshire Hathaway Inc. and related entities report beneficial ownership of 13,400,000 shares of Constellation’s common stock, representing 7.6% of the class as of the event date of 09/30/2025. National Indemnity Company, GEICO Corporation and Government Employees Insurance Company each report beneficial ownership of 13,000,000 shares, or 7.4% of the class, while Precision Castparts Corp. Master Trust reports 400,000 shares, or 0.2%. The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Constellation Brands.
Capital World Investors filed an amended Schedule 13G reporting beneficial ownership of 6,781,286 Constellation Brands (STZ) common shares, equal to 3.8% of the class, with a Date of Event of 09/30/2025. The filing is on a passive ownership schedule and identifies the reporting person as an investment adviser (IA).
The firm reports sole voting power over 6,658,123 shares and sole dispositive power over 6,781,286 shares, with no shared voting or dispositive power. The percentage is based on 176,266,239 shares believed outstanding. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Constellation Brands, Inc. filed an automatic shelf registration statement on Form S-3 and a related prospectus supplement registering the resale of up to 21,274,829 shares of its Class A Common Stock. The selling stockholders named in the supplement may use it to resell these shares.
The company stated it will not receive any proceeds from sales by the selling stockholders. The filing also includes a legal opinion on the validity of the shares as Exhibit 5.1, which is incorporated by reference.
Constellation Brands, Inc. filed an automatic shelf registration statement on Form S-3 as a well-known seasoned issuer. The shelf allows the company to offer, from time to time, debt securities, preferred stock, depositary shares, Class A common stock, warrants, subscription rights, purchase contracts, and purchase units, with final terms to be set in prospectus supplements.
Selling stockholders named in future supplements may also resell shares of Class A common stock, and the company states it will not receive any proceeds from those stockholder sales. Net proceeds to the company from any primary offerings are intended for general corporate purposes, including repayment or refinancing of indebtedness, working capital, capital expenditures, share repurchases, dividends, and acquisitions. Constellation’s Class A common stock trades on the NYSE under the symbol STZ.